About Us

Our Mission to Transform
Patient Lives

Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer and autoimmune diseases. We utilize T cells from donors with healthy immune function, with the goal to specifically recognize and target cancerous or diseased cells in patients without affecting normal cells. Our investigational off-the-shelf T cells are intended for rapid delivery from inventory to patients.

Our Mission

Transform the lives of patients with serious diseases through pioneering science, teamwork, and a commitment to excellence

Our Proprietary T-Cell Immunotherapy Technology Platform

Our Proprietary T-Cell Immunotherapy Technology Platform

Our unique platform is to create off-the-shelf, allogeneic T-cell libraries that can be used to select the appropriate cells for a patient's unique immune profile.

View Technology

Our Pipeline

Our robust pipeline features multiple T-cell immunotherapies in clinical and pre-clinical development

Tabelecleucel (tab-cel®)

T-cell immunotherapy for EBV-associated ultra-rare diseases

FDA breakthrough designation & EMA PRIME for EBV+ PTLD

ATA188
EBV T-cell immunotherapy for progressive multiple sclerosis (MS)
ATA2271/ATA3271
Mesothelin CAR T for solid tumors
ATA3219

EBV CD19 CAR T

Next-generation off-the-shelf, allogeneic CD19-1XX CAR+ EBV T-cell immunotherapy containing a modified CD3ζ signaling domain, 1XX

Patient Stories

“Don’t give up. That’s the main thing.”
- Ayden Kidney transplant, PTLD Advocate
“When somebody calls and says I’ve affected their life in a positive way—there’s not much better feeling than that. Especially knowing what people go through with this disease.”
- Mitch MS Advocate
“You have two options after you get a diagnosis: You can deny it or live it. I am choosing to live it. I am living the best I can with this disease.”
- Dan MS Advocate
“I am who I am because of my disability. People read my story and say, ‘You are a role model to me.’ Hearing that from others is what drives me forward.”
- Ola Heart and kidney transplant, PTLD Advocate
“I have found my passion in speaking and creating a larger platform—to use the experiences I have gone through to improve healthcare for all stakeholders.”
- Swapna Small intestine transplant, PTLD Advocate
“With my new lungs, I could walk up a flight of stairs without wheezing. I could breathe.”
- Allison Double lung transplant, PTLD Advocate
Ayden Mitch Dan Ola Swapna Allison
View Patient Stories
Ayden

Patient Stories

“Don’t give up. That’s the main thing.”
Ayden
Mitch

Patient Stories

“When somebody calls and says I’ve affected their life in a positive way—there’s not much better feeling than that. Especially knowing what people go through with this disease.”
Mitch
Dan

Patient Stories

“You have two options after you get a diagnosis: You can deny it or live it. I am choosing to live it. I am living the best I can with this disease.”
Dan
Ola

Patient Stories

“I am who I am because of my disability. People read my story and say, ‘You are a role model to me.’ Hearing that from others is what drives me forward.”
Ola
Swapna

Patient Stories

“I have found my passion in speaking and creating a larger platform—to use the experiences I have gone through to improve healthcare for all stakeholders.”
Swapna
Allison

Patient Stories

“With my new lungs, I could walk up a flight of stairs without wheezing. I could breathe.”
Allison
View Patient Stories